Riskpilot← Back to searchSign inGet full accessPer Nilsson Medicinkonsult AB
ABIn liquidationOrg 5566229067Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20020 employees
Revenue 2022
SEK 0
EBITDA margin
—
-217% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
SEK -35K
-190% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -35K | -217% |
| Net profit | SEK -35K | -190% |
| Total assets | SEK 84K | -32% |
| Equity | SEK 84K | +31% |
| Employees | 0 | — |
Legal name
Per Nilsson Medicinkonsult AB
Org number
5566229067
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
25 januari 2002
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva läkar- och sjukvårdsverksamhet, medicinsk konsult- och utbildningsverksamhet samt äga och förvalta lös och fast egendom och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 43 | 19 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 | −25 | −19 | −11 | −35 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 4 | −25 | −19 | −11 | −35 |
| Net financials | 52 | — | — | −1 | −0 |
| Profit before tax | 56 | −25 | −19 | −12 | −35 |
| Tax | −0 | −0 | −0 | −0 | — |
| Net profit | 56 | −25 | −19 | −12 | −35 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 191 | 161 | 137 | 124 | 84 |
| Equity | 176 | 95 | 76 | 64 | 84 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 15 | 66 | 61 | 61 | 0 |
| Total debt | 15 | 66 | 61 | 61 | — |
EBITDA margin
-3484400.0%
This company
15.8%
Market median
-22053265% vs market
20182022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182022
Return on equity
-41.4%
This company
18.4%
Market median
-325% vs market
20182022
Net profit margin
-3485700.0%
This company
8.1%
Market median
-43033433% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SI Liquidator | Liquidator | 2022 |
| Former (1) | ||
AA Liquidator | Liquidator | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Per Nilsson Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Amanda Andrén | Liquidator | 0 companies |
| Susanne I Pettersson Ejderstav | Liquidator | 0 companies |
| Maria Ingrid Carola Nilsson | Deputy Board Member | 0 companies |
| Per Uno Nilsson | Board of Directors | 0 companies |